, Quelle est l'importance de la raideur de votre articulation lorsque vous vous levez le matin ?
, Quelle est l'importance de la raideur de votre articulation lorsque vous bougez après vous être assis, couché ou reposé durant la journée ? 3. WOMAC Domaine fonction : quelle est l'importance de la difficulté que vous éprouvez à
, Descendre les escaliers ?
, Monter les escaliers ?
, Vous relever de la position assise ?
, Vous tenir debout ?
, Vous pencher en avant ?
, Marcher en terrain plat ?
, Entrer et sortir d'une voiture ?
, Faire vos courses ?
, Enlever vos collants ou vos chaussettes ?
, Vous étendre sur le lit ?
, Entrer ou sortir d'une baignoire ? 17. Vous asseoir ?
, Vous asseoir et vous relever des toilettes ?
, Faire le ménage " à fond " de votre domicile ?
, Faire l'entretien quotidien de votre domicile ? Annexe 10: Comparaison des critères de douleur et des scores cliniques entre le groupe PRP
« Mechanical and constitutional risk factors for symptomatic knee osteoarthritis: differences between medial tibiofemoral and patellofemoral disease, J. Rheumatol, vol.21, issue.2, pp.307-313, 1994. ,
, Inserm -La science pour la santé, vol.20, 2019.
, Actual. Pharm, vol.55, pp.18-22, 2016.
« Prevalence of symptomatic hip and knee osteoarthritis: a two-phase population-based survey1, Osteoarthritis Cartilage, vol.19, issue.11, pp.1314-1322, 2011. ,
« The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review, Osteoarthritis Cartilage, vol.19, pp.1270-1285, 2011. ,
« Lifetime risk of symptomatic knee osteoarthritis, Arthritis Rheum, vol.59, issue.9, pp.1207-1213, 2008. ,
, Français des Enseignants en Rhumatologie(COFER), 2019.
The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis, Nat. Rev. Rheumatol, vol.6, issue.11, pp.625-635, 2010. ,
Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritisresults of a 1 year longitudinal arthroscopic study in 422 patients, Osteoarthritis Cartilage, vol.13, issue.5, pp.361-367, 2005. ,
« Mechanical loading highly increases IL-6 production and decreases OPG expression by osteoblasts, Osteoarthritis Cartilage, vol.17, issue.4, pp.473-481, 2009. ,
« Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee », Arthritis Rheum, vol.29, issue.8, pp.1039-1049, 1986. ,
« Dkfinition et Cpidkmiologie de la gonarthrose, p.8 ,
« Whole-Organ Magnetic Resonance Imaging Score (WORMS) of the knee in osteoarthritis, Osteoarthritis Cartilage, vol.12, issue.3, pp.177-190, 2004. ,
« MRI assessment of knee osteoarthritis: Knee Osteoarthritis Scoring System (KOSS)--inter-observer and intra-observer reproducibility of a compartment-based scoring system, Skeletal Radiol, vol.34, issue.2, pp.95-102, 2005. ,
« The reliability of a new scoring system for knee osteoarthritis MRI and the validity of bone marrow lesion assessment: BLOKS (Boston-Leeds Osteoarthritis Knee Score) », Ann. Rheum. Dis, vol.67, issue.2, pp.206-211, 2008. ,
« Evolution of semi-quantitative whole joint assessment of knee OA: MOAKS (MRI Osteoarthritis Knee Score), Osteoarthritis Cartilage, vol.19, issue.8, pp.990-1002, 2011. ,
« Recommendations for a Core Set of Outcome Measures for Future Phase III Clinical Trials in Knee, Hip, and Hand Osteoarthritis. Consensus Development at OMERACT III », J. Rheumatol, p.5 ,
Using patients' and rheumatologists' opinions to specify a short form of the WOMAC function subscale, Ann. Rheum. Dis, vol.64, issue.1, pp.75-79, 2005. ,
,
« The development of a short measure of physical function for knee OA KOOS-Physical Function Shortform (KOOS-PS) -an OARSI/OMERACT initiative », Osteoarthritis Cartilage, vol.16, pp.542-550, 2008. ,
« Defining clinically meaningful change in health-related quality of life, J. Clin. Epidemiol, vol.56, issue.5, pp.395-407, 2003. ,
« Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials, BMJ, vol.329, p.324, 2004. ,
, , 2019.
, Place des corticoïdes en intra-articulaire chez l'adulte, vol.1, pp.39673-39674, 2006.
« Les injections intra-articulaires », Rev Med Brux, p.7, 2015. ,
, « Thériault -2006 -de substances corticoïdes
2006 -Intraarticular corticosteroid for treatment of ost ,
2009 -Therapeutic trajectory of hyaluronic acid versus c ,
2015 -Intra-articular corticosteroid for knee osteoarthr ,
2016 -Evidence and recommendations for use of intra-arti ,
« OARSI recommendations for the management of hip and knee osteoarthritis, Osteoarthritis Cartilage, vol.18, issue.4, pp.476-499 ,
« OARSI guidelines for the non-surgical management of knee osteoarthritis, Osteoarthritis Cartilage, vol.22, issue.3, pp.363-388, 2014. ,
College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee », Arthritis Care Res, vol.64, issue.4, pp.465-474 ,
Inserm -La science pour la santé, 2019. ,
, « Intra-articular Corticosteroid Injections in the Hip and Knee: Perhaps Not as Safe as We Thought? », Radiology, vol.293, pp.656-663
« Evidence and recommendations for use of intra-articular injections for knee osteoarthritis, Ann. Phys. Rehabil. Med, vol.59, issue.3, pp.184-189, 2016. ,
« Hyaluronan for knee osteoarthritis: an updated meta-analysis of trials with low risk of bias, RMD Open, vol.1, issue.1, pp.71-000071, 2015. ,
, , 2019.
, déremboursement effectif d'OSTENIL et d'ARTHRUM à partir du 1er décembre, 2017.
, « Question n°99179 -Assemblée nationale, vol.12, 2020.
« Management of knee osteoarthritis: Knee lavage combined with intra articular injections of methyl prednisolone », Int. J. Orthop. Sci, vol.4, issue.2, pp.169-174, 2018. ,
, , 2019.
« How long does a hip replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up, The Lancet, vol.393, issue.18, pp.31665-31674 ,
, Code de la sécurité sociale -Article L161-37, pp.161-198
« Cadre réglementaire de la thérapie cellulaire, Bull. Cancer (Paris), vol.90, issue.8, pp.779-788, 2003. ,
Agence nationale de sécurité du médicament et des produits de santé, 2019. ,
, , 2019.
, « Code de la santé publique -Article L1221-8 | Legifrance, 2020.
, , vol.375056, 2020.
, 1394/2007 du Parlement européen et du Conseil du 13 novembre 2007 concernant les médicaments de thérapie innovante et modifiant la directive 2001/83/CE ainsi que le règlement (CE), vol.726, 2004.
, mins-Features, « Why Are There Only 10 Cell and Gene Therapies in Europe?, 2018.
, -302 du 22 mars 2011 portant diverses dispositions d'adaptation de la législation au droit de l'Union européenne en matière de santé, de travail et de communications électroniques, 2011.
, Code de la santé publique -Article L5121-1, pp.5121-5122
, , p.24
,
, Code de la santé publique -Article L1245-2, pp.1245-1247
, Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte-and platelet-rich fibrin (L-PRF), vol.27, pp.158-167, 2009.
, Platelet-Rich Plasma Releasate Inhibits Inflammatory Processes in Osteoarthritic Chondrocytes, 2011.
Aghebati-Maleki, « Platelet rich plasma, stromal vascular fraction and autologous conditioned serum in treatment of knee osteoarthritis », Biomed. Pharmacother, vol.104, pp.652-660, 2018. ,
At the Dawn of an Off-the-Shelf Therapy? -PubMed -NCBI, vol.10, 2020. ,
« The production of anti-inflammatory cytokines in whole blood by physico-chemical induction », Inflamm. Res, vol.52, issue.10, pp.404-407, 2003. ,
« Intra-articular Treatment of Knee Osteoarthritis: from Anti-inflammatories to Products of Regenerative Medicine, Phys. Sportsmed, vol.44, issue.2, pp.101-108, 2016. ,
« Autologous conditioned serum for the treatment of osteoarthritis and other possible applications in musculoskeletal disorders », Br. Med. Bull, vol.105, pp.169-184, 2013. ,
« Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein, Nature, vol.344, pp.633-638 ,
« Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor, Nature, vol.343, pp.336-340 ,
« Bone marrow concentrate and platelet-rich plasma differ in cell distribution and interleukin 1 receptor antagonist protein concentration, Knee Surg. Sports Traumatol. Arthrosc. Off. J. ESSKA, vol.26, issue.1, pp.333-342, 2018. ,
« The Basic Science of Bone Marrow Aspirate Concentrate in Chondral Injuries », Orthop. Rev, vol.8, issue.3, p.6659, 2016. ,
« The role of growth factors in cartilage repair, Clin. Orthop, vol.469, issue.10, pp.2706-2715, 2011. ,
« Two major Smad pathways in TGF-beta superfamily signalling, Genes Cells Devoted Mol. Cell. Mech, vol.7, pp.1191-1204 ,
, Clinical Trials With Mesenchymal Stem Cells: An Update, vol.25, issue.5, pp.829-848, 2016.
Fractured and Purified Adipose Tissue Graft (Lipogems®) Can Improve the Orthognathic Surgery Outcomes Both Aesthetically and in Postoperative Healing -CellR4, 2020. ,
« Conventional vs. micro-fat harvesting: How fat harvesting technique affects tissue-engineering approaches using adipose tissue-derived stem/stromal cells, J. Plast. Reconstr. Aesthet. Surg, vol.66, issue.9, pp.1271-1278 ,
« Combined use of platelet rich plasma & micro-fat in sport and race horses with degenerative joint disease: preliminary clinical study in eight horses, p.7 ,
« Development of Autologous Platelet-Rich Plasma Mixed-Microfat as an Advanced Therapy Medicinal Product for Intra-Articular Injection of Radio-Carpal Osteoarthritis: From Validation Data to Preliminary Clinical Results », Int. J. Mol. Sci, vol.20, issue.5, p.2019 ,
« Combined use of platelet rich plasma & micro-fat in sport and race horses with degenerative joint disease: preliminary clinical study in eight horses, Muscles Ligaments Tendons J, vol.6, issue.2, pp.198-204 ,
« Metabolism of isolated fat cells. 3. The similar inhibitory action of phospholipase C (Clostridium perfringens alpha toxin) and of insulin on lipolysis stimulated by lipolytic hormones and theophylline, J. Biol. Chem, vol.241, issue.1, pp.140-142, 1966. ,
« Adipose-derived stem cells for regenerative medicine », Circ. Res, vol.100, issue.9, pp.1249-1260, 2007. ,
« Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells, Circulation, vol.109, issue.10, pp.1292-1298, 2004. ,
« Surface protein characterization of human adipose tissue-derived stromal cells, J. Cell. Physiol, vol.189, issue.1, pp.54-63, 2001. ,
« Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, vol.8, issue.4, pp.315-317, 2006. ,
« Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord, Stem Cells Dayt. Ohio, vol.21, issue.1, pp.105-110, 2003. ,
« Human placentaderived cells have mesenchymal stem/progenitor cell potential, Stem Cells Dayt. Ohio, vol.22, issue.5, pp.649-658, 2004. ,
« Multipotent mesenchymal stem cells from adult human synovial membrane, Arthritis Rheum, vol.44, issue.8, 1928. ,
« Cell specific differences between human adipose-derived and mesenchymalstromal cells despite similar differentiation potentials, Exp. Cell Res, vol.314, issue.7, pp.1575-1584, 2008. ,
, Cellules souches mésenchymateuses et médecine régénératrice -Quel avenir pour l'arthrose ? », médecine/sciences, vol.34, pp.1092-1099, 2018.
« Preclinical Studies of Stem Cell Therapy for Heart Disease », Circ. Res, vol.122, issue.7, pp.1006-1020, 2018. ,
« Multilineage cells from human adipose tissue: implications for cell-based therapies, Tissue Eng, vol.7, issue.2, pp.211-228, 2001. ,
« Methods of Isolation, Characterization and Expansion of Human Adipose-Derived Stem Cells (ASCs): An Overview », Int. J. Mol. Sci, vol.19, issue.7, p.1897, 2018. ,
, Cellules souches mésenchymateuses et immunomodulation : intérêt en thérapie cellulaire et risques potentiels », vol.14, p.5, 2008.
« Mesenchymal stem cells: immune evasive, not immune privileged, Nat. Biotechnol, vol.32, issue.3, p.252, 2014. ,
« Human mesenchymal stem cells modulate allogeneic immune cell responses, Blood, vol.105, pp.1815-1822, 2005. ,
« Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far? », Immunol, Cell Biol, vol.91, issue.1, pp.40-51 ,
« Innovative regenerative medicine in the management of knee OA: The role of Autologous Protein Solution, J. Clin. Orthop. Trauma, vol.10, issue.1, pp.49-52 ,
Woodell-May, « Blood-derived anti-inflammatory protein solution blocks the effect of IL-1? on human macrophages in vitro », Inflamm. Res, vol.60, issue.10, p.929, 2011. ,
Woodell-May, « Autologous solution protects bovine cartilage explants from IL-1?-and TNF?-induced cartilage degradation, J. Orthop. Res, vol.31, pp.1929-1935, 2013. ,
« Evaluation of a single intra-articular injection of autologous protein solution for treatment of osteoarthritis in horses, Am. J. Vet. Res, vol.75, issue.2, pp.141-151, 2014. ,
Woodell-May, « White blood cell concentration correlates with increased concentrations of IL-1ra and improvement in WOMAC pain scores in an open-label safety study of autologous protein solution, J. Exp. Orthop, vol.3, issue.1, p.9, 2016. ,
Amniotic Suspension Allograft Modulates Inflammation in a Rat Pain Model of Osteoarthritis, J. Orthop. Res ,
« Amniotic Tissue Modulation of Knee Pain-A Focus on Osteoarthritis, J. Knee Surg, vol.32, pp.26-036 ,
, ReNu -Product Information, 2020.
« Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Meta-analysis of Randomized Controlled Trials, Arthrosc. J. Arthrosc. Relat. Surg, vol.33, issue.3, p.2017 ,
Allogeneic platelet rich plasma serves as a scaffold for articular cartilage derived chondroprogenitors, Tissue Cell, vol.56, pp.107-113 ,
« Evaluation of allogeneic freeze-dried platelet lysate in cartilage exposed to interleukin 1-? in vitro, BMC Vet. Res, vol.15, issue.1, p.386, 2019. ,
« Tenogenically Induced Allogeneic Peripheral Blood Mesenchymal Stem Cells in Allogeneic Platelet-Rich Plasma: 2-Year Follow-up after Tendon or Ligament Treatment in Horses, Front. Vet. Sci, vol.4, p.158, 2017. ,
« Allogeneic Platelet-Rich Plasma Therapy as an Effective and Safe Adjuvant Method for Chronic Wounds, J. Surg. Res, vol.246, pp.284-291, 2020. ,
, Allogenic Pure Platelet-Rich Plasma Therapy for Rotator Cuff Disease: A Bench and Bed Study, vol.46, pp.3142-3154, 2018.
« Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis, Osteoarthritis Cartilage, vol.17, issue.2, pp.152-160, 2009. ,
Single-Blind, Placebo-Controlled Trial of Bone Marrow Aspirate Concentrate for Knee Osteoarthritis », Am. J. Sports Med, vol.45, issue.1, pp.82-90, 2017. ,
« Clinical Efficacy of Intra-articular Mesenchymal Stromal Cells for the Treatment of Knee Osteoarthritis: A Double-Blinded Prospective Randomized Controlled Clinical Trial », Am. J. Sports Med, vol.48, issue.3, pp.588-598 ,
Adipose Mesenchymal Stromal Cell-Based Therapy for Severe Osteoarthritis of the Knee: A Phase I Dose-Escalation Trial: ASCs for Severe OA of the Knee », STEM CELLS Transl. Med, vol.5, issue.7, pp.847-856, 2016. ,
« Intra-Articular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Phase IIb, Randomized, Placebo-Controlled Clinical Trial, Stem Cells Transl. Med, vol.8, issue.6, pp.504-511, 2019. ,
« Clinical Outcomes of Knee Osteoarthritis Treated With an Autologous Protein Solution Injection: A 1-Year Pilot Double-Blinded Randomized Controlled Trial », Am. J. Sports Med, vol.46, issue.1, pp.171-180, 2018. ,
« A Randomized Controlled Single-Blind Study Demonstrating Superiority of Amniotic Suspension Allograft Injection Over Hyaluronic Acid and Saline Control for Modification of Knee Osteoarthritis Symptoms, J. Knee Surg, vol.32, issue.11, pp.1143-1154, 2019. ,
, Regenerative Medicine: Injectable Cell-Based Therapeutics and Approved Products, vol.7, pp.75-95, 2019.
« Evaluation of Intraoperative Retention of Autologous Chondrocytes on Type I/III Collagen Scaffold (Ortho-ACI TM ) for Cartilage Repair, J. Foot Ankle Res, vol.8, issue.S2, p.10, 1146. ,
« Arthroscopic autologous chondrocyte implantation in the glenohumeral joint: a case report, J. Shoulder Elbow Surg, vol.27, issue.10, pp.300-307, 2018. ,
Phase III Noninferiority Trial to Compare the Clinical Efficacy of Matrix-Associated Autologous Chondrocyte Implantation With Spheroid Technology Versus Arthroscopic Microfracture for Cartilage Defects of the Knee », Orthop. J. Sports Med, vol.7, issue.7, p.232596711985444 ,
« Implantation of allogenic umbilical cord blood-derived mesenchymal stem cells improves knee osteoarthritis outcomes: Two-year follow-up, Regen. Ther, vol.14, pp.32-39 ,
« Gel-type autologous chondrocyte (Chondron TM ) implantation for treatment of articular cartilage defects of the knee, BMC Musculoskelet. Disord, vol.11, issue.1, p.103 ,
« Trends in clinical trials for articular cartilage repair by cell therapy, NPJ Regen. Med, vol.3, 2018. ,
« Matrix-Applied Characterized Autologous Cultured Chondrocytes Versus Microfracture: Two-Year Follow-up of a Prospective Randomized Trial », Am. J. Sports Med, vol.42, issue.6, pp.1384-1394, 2014. ,
« Autologous platelet-rich plasma in cardiac surgery: effect on intraoperative and postoperative transfusion requirements, Ann. Thorac. Surg, vol.46, issue.4, pp.64655-64658, 1988. ,
« Annual Cost of Patients with Osteoarthritis of the Hip and Knee in France, J. Musculoskelet. Pain, vol.22, issue.4, pp.356-364 ,
« Knee OA management: A cost-effectiveness analysis of platelet-rich-plasma versus hyaluronic acid for the intra-articular treatment of knee OA in France », Int. J. Clin. Rheumatol, 2018. ,
, , 2020.